Advertisement

Drugs & Aging

, Volume 35, Issue 1, pp 43–60 | Cite as

Tools for Assessment of the Appropriateness of Prescribing and Association with Patient-Related Outcomes: A Systematic Review

  • Nashwa MasnoonEmail author
  • Sepehr Shakib
  • Lisa Kalisch-Ellett
  • Gillian E. Caughey
Systematic Review

Abstract

Background

There are tools and criteria in the literature aimed at distinguishing between appropriate and inappropriate medicines use. However, many have not been externally validated with regard to patient-related outcomes, potentially limiting their use in clinical practice.

Objectives

The aim of the study was to conduct a systematic review to summarise (1) available prescribing appropriateness assessment tools and criteria, and (2) their associations with patient-related outcomes (external validity).

Methods

A systematic review was conducted using MEDLINE, EMBASE and Informit (Health Collection) databases to screen for articles in English that examined (1) tools to assess the appropriateness of prescribing and (2) associations of tools with patient-related outcomes, published between 2000 and 2016, without any limits placed on the study design, participant age or setting.

Results

After screening 1710 articles, removing duplicates and shortlisting relevant articles, 42 prescribing assessment tools were identified. Out of the 42 tools, 78.6% (n = 33) provided guidance around stopping inappropriate medications, 28.6% (n = 12) around starting appropriate medications, 61.9% (n = 26) were explicit (criteria based) and 31.0% (n = 13) had been externally validated, with hospitalisation being the most commonly used patient-related outcome (n = 9, 21.4%).

Conclusion

The results of this systematic review highlight the need for evidence-based and externally validated tools, which combine the different aspects of medication management to optimise patient-related outcomes. PROSPERO registration number: CRD42017067233.

Notes

Compliance with Ethical Standards

Funding

Nashwa Masnoon is supported by an Australian Government Research Training Program (RTP). No other sources of funding were used to assist in the preparation of this article.

Conflicts of interest

Nashwa Masnoon, Sepehr Shakib, Lisa Kalisch-Ellett and Gillian Caughey declare that they have no conflicts of interest relevant to the content of this review.

Supplementary material

40266_2018_516_MOESM1_ESM.xlsx (28 kb)
Supplementary material 1 (XLSX 28 kb)

References

  1. 1.
    Salive ME. Multimorbidity in older adults. Epidemiol Rev. 2013.  https://doi.org/10.1093/epirev/mxs009.PubMedGoogle Scholar
  2. 2.
    Roughead EE, Vitry AI, Caughey GE, et al. Multimorbidity, care complexity and prescribing for the elderly. Aging Health. 2011;7(5):695–705.  https://doi.org/10.2217/ahe.11.64.CrossRefGoogle Scholar
  3. 3.
    Caughey GE, Ramsay EN, Vitry AI, et al. Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study. J Epidemiol Community Health. 2010;64(12):1036–42.  https://doi.org/10.1136/jech.2009.088260.PubMedCrossRefGoogle Scholar
  4. 4.
    Marengoni A, Angleman S, Melis R, et al. Aging with multimorbidity: a systematic review of the literature. Aging Res Rev. 2011;10(4):430–9.  https://doi.org/10.1016/j.arr.2011.03.003.CrossRefGoogle Scholar
  5. 5.
    Vitry AI, Zhang Y. Quality of Australian clinical guidelines and relevance to the care of older people with multiple comorbid conditions. Med J Aust. 2008;189(7):360–5.PubMedGoogle Scholar
  6. 6.
    Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716–24.  https://doi.org/10.1001/jama.294.6.716.PubMedCrossRefGoogle Scholar
  7. 7.
    Milton JC, Hill-Smith I, Jackson SHD. Prescribing for older people. BMJ. 2008;336(7644):606–9.  https://doi.org/10.1136/bmj.39503.424653.80.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Caughey GE, Roughead EE, Pratt N, et al. Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing? Pharmacoepidemiol Drug Saf. 2010;19(9):977–82.  https://doi.org/10.1002/pds.2009.PubMedCrossRefGoogle Scholar
  9. 9.
    Caughey GE, Roughead EE, Vitry AI, et al. Comorbidity in the elderly with diabetes: identification of areas of potential treatment conflicts. Diabetes Res Clin Pract. 2010;87(3):385–93.  https://doi.org/10.1016/j.diabres.2009.10.019.PubMedCrossRefGoogle Scholar
  10. 10.
    Fried TR, O’Leary J, Towle V, et al. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62(12):2261–72.  https://doi.org/10.1111/jgs.13153.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Bushardt RL, Massey EB, Simpson TW, et al. Polypharmacy: misleading, but manageable. Clin Interv Aging. 2008;3(2):383–9.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Shimizu K, Ishii S, Tanaka T, et al. Use of potentially inappropriate medication and polypharmacy in community-dwelling Japanese elderly population from the Kashiwa study. J Am Geriatr Soc. 2014;62:S249–50.  https://doi.org/10.1111/jgs.12870.Google Scholar
  13. 13.
    Sato I, Akazawa M. Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study. Drug Healthc Patient Saf. 2013;5(1):143–50.  https://doi.org/10.2147/DHPS.S45347.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Epidemiol Community Health. 2012;65(9):989–95.  https://doi.org/10.1016/j.jclinepi.2012.02.018.Google Scholar
  15. 15.
    Fulton MM, Riley Allen E. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract. 2005;17(4):123–32.  https://doi.org/10.1111/j.1041-2972.2005.0020.x.PubMedCrossRefGoogle Scholar
  16. 16.
    Masnoon N, Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230.  https://doi.org/10.1186/s12877-017-0621-2.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Pollock M, Bazaldua OV, Dobbie AE. Appropriate prescribing of medications: an eight-step approach. Am Fam Physician. 2007;75(2):231–6.PubMedGoogle Scholar
  18. 18.
    NPS MEDICINEWISE. Identifying inappropriate prescribing. In: Older people & medicines. 2013. http://www.nps.org.au/topics/ages-life-stages/for-individuals/older-people-and-medicines/for-health-professionals/inappropriate-prescribing. Accessed 15 March 2017.
  19. 19.
    Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167(8):781–7.  https://doi.org/10.1001/archinte.167.8.781.PubMedCrossRefGoogle Scholar
  20. 20.
    Rudolph JL, Salow MJ, Angelini MC, et al. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168(5):508–13.  https://doi.org/10.1001/archinternmed.2007.106.PubMedCrossRefGoogle Scholar
  21. 21.
    Carnahan RM, Lund BC, Perry PJ, et al. The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006;46(12):1481–6.  https://doi.org/10.1177/0091270006292126.PubMedCrossRefGoogle Scholar
  22. 22.
    American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–46.  https://doi.org/10.1111/jgs.13702.CrossRefGoogle Scholar
  23. 23.
    Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.PubMedCrossRefGoogle Scholar
  24. 24.
    Kouladjian L, Gnjidic D, Chen TF, et al. Drug burden index in older adults: theoretical and practical issues. Clin Interv Aging. 2014;9:1503–15.  https://doi.org/10.2147/CIA.S66660.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.  https://doi.org/10.1371/journal.pmed.1000097.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    CASP UK. CASP Checklists. In: Critical Appraisal Skills Programme (CASP) Making sense of evidence. CASP UK. 2017. https://www.casp-uk.net/casp-tools-checklists. Accessed 10 May 2017.
  27. 27.
    Holmes HM, Sachs GA, Shega JW, et al. Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. J Am Geriatr Soc. 2008;56(7):1306–11.  https://doi.org/10.1111/j.1532-5415.2008.01741.x.PubMedCrossRefGoogle Scholar
  28. 28.
    Tommelein E, Petrovic M, Somers A, et al. Older patients’ prescriptions screening in the community pharmacy: development of the Ghent Older People’s Prescriptions community Pharmacy Screening (GheOP3S) tool. J Public Health (Oxf). 2016;38(2):e158–70.  https://doi.org/10.1093/pubmed/fdv090.CrossRefGoogle Scholar
  29. 29.
    Berdot S, Bertrand M, Dartigues J-F, et al. Inappropriate medication use and risk of falls—a prospective study in a large community-dwelling elderly cohort. BMC Geriatr. 2009;9:30.  https://doi.org/10.1186/1471-2318-9-30.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA. 2001;286(22):2823–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Winit-Watjana W, Sakulrat P, Kespichayawattana J. Criteria for high-risk medication use in Thai older patients. Arch Gerontol Geriatr. 2008;47(1):35–51.  https://doi.org/10.1016/j.archger.2007.06.006.PubMedCrossRefGoogle Scholar
  32. 32.
    Niehoff KM, Rajeevan N, Charpentier PA, et al. Development of the tool to reduce inappropriate medications (TRIM): a clinical decision support system to improve medication prescribing for older adults. Pharmacotherapy. 2016;36(6):694–701.  https://doi.org/10.1002/phar.1751.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Rancourt C, Moisan J, Baillargeon L, et al. Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatr. 2004;4:9.  https://doi.org/10.1186/1471-2318-4-9.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    PrescQIPP. Optimising safe and appropriate medicines use. 2017. https://www.prescqipp.info/projects/optimising-safe-and-appropriate-medicines-use. Accessed 2 Nov 2017.
  35. 35.
    Nyborg G, Straand J, Klovning A, et al. The Norwegian General Practice-Nursing Home criteria (NORGEP-NH) for potentially inappropriate medication use: a web-based Delphi study. Scand J Primary Health Care. 2015;33(2):134–41.  https://doi.org/10.3109/02813432.2015.1041833.CrossRefGoogle Scholar
  36. 36.
    Mimica Matanovic S, Vlahovic-Palcevski V. Potentially inappropriate medications in the elderly: a comprehensive protocol. Eur J Clin Pharmacol. 2012;68(8):1123–38.  https://doi.org/10.1007/s00228-012-1238-1.PubMedCrossRefGoogle Scholar
  37. 37.
    Kojima T, Mizukami K, Tomita N, et al. Screening tool for older persons’ appropriate prescriptions for Japanese: Report of the Japan Geriatrics Society Working Group on “Guidelines for Medical Treatment and its Safety in the Elderly”. Geriatr Gerontol Int. 2016;16(9):983–1001.  https://doi.org/10.1111/ggi.12890.PubMedCrossRefGoogle Scholar
  38. 38.
    Maio V, Del Canale S, Abouzaid S. Using explicit criteria to evaluate the quality of prescribing in elderly Italian outpatients: a cohort study. J Clin Pharm Ther. 2010;35(2):219–29.  https://doi.org/10.1111/j.1365-537(2710).2009.01094.x.PubMedCrossRefGoogle Scholar
  39. 39.
    Renom-Guiteras A, Meyer G, Thürmann PA. The EU(7)-PIM List: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol. 2015;71(7):861–75.  https://doi.org/10.1007/s00228-015-1860-9.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care. 2003;12(3):176–80.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Mann E, Bohmdorfer B, Fruhwald T, et al. Potentially inappropriate medication in geriatric patients: the Austrian Consensus Panel List. Wien Klin Wochenschr. 2012;124(5–6):160–9.  https://doi.org/10.1007/s00508-011-0061-5.PubMedCrossRefGoogle Scholar
  42. 42.
    Hassan NB, Ismail HC, Naing L, et al. Development and validation of a new prescription quality index. Br J Clin Pharmacol. 2010;70(4):500–13.  https://doi.org/10.1111/j.1365-2125.2009.03597.x.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Lewis T. Using the NO TEARS tool for medication review. BMJ. 2004;329(7463):434.  https://doi.org/10.1136/bmj.329.7463.434.PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Basger BJ, Chen TF, Moles RJ. Validation of prescribing appropriateness criteria for older Australians using the RAND/UCLA appropriateness method. BMJ Open. 2012.  https://doi.org/10.1136/bmjopen-2012-001431.PubMedPubMedCentralGoogle Scholar
  45. 45.
    Drenth-van Maanen AC, van Marum RJ, Knol W, et al. Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy: results of application to case histories by general practitioners. Drugs Aging. 2009;26(8):687–701.  https://doi.org/10.2165/11316400-000000000-00000.PubMedCrossRefGoogle Scholar
  46. 46.
    Roth MT, Ivey JL, Esserman DA, et al. Individualized medication assessment and planning: optimizing medication use in older adults in the primary care setting. Pharmacotherapy. 2013;33(8):787–97.  https://doi.org/10.1002/phar.1274.PubMedCrossRefGoogle Scholar
  47. 47.
    Haque RM. ARMOR: a tool to evaluate polypharmacy in elderly persons. Ann Long-Term Care. 2009;17(6):26–30.Google Scholar
  48. 48.
    Lee SS, Schwemm AK, Reist J, et al. Pharmacists’ and pharmacy students’ ability to identify drug-related problems using TIMER (Tool to Improve Medications in the Elderly via Review). Am J Pharmaceut Educ. 2009;73(3):52.CrossRefGoogle Scholar
  49. 49.
    McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ. 1997;156(3):385–91.PubMedPubMedCentralGoogle Scholar
  50. 50.
    National Committee for Quality Assurance. HEDIS 2016. 2016.Google Scholar
  51. 51.
    Van der Linden L, Decoutere L, Flamaing J, et al. Development and validation of the RASP list (Rationalization of Home Medication by an Adjusted STOPP list in Older Patients): a novel tool in the management of geriatric polypharmacy. Eur Geriatr Med. 2014;5(3):175–80.  https://doi.org/10.1016/j.eurger.2013.12.005.CrossRefGoogle Scholar
  52. 52.
    Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63(8):725–31.  https://doi.org/10.1007/s00228-007-0324-2.PubMedCrossRefGoogle Scholar
  53. 53.
    Wenger NS, Roth CP, Shekelle P. Introduction to the assessing care of vulnerable elders-3 quality indicator measurement set. J Am Geriatr Soc. 2007;55(Suppl 2):S247–52.  https://doi.org/10.1111/j.1532-5415.2007.01328.x.PubMedCrossRefGoogle Scholar
  54. 54.
    Naugler CT, Brymer C, Stolee P, et al. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol. 2000;7(2):103–7.PubMedGoogle Scholar
  55. 55.
    Kuhn-Thiel AM, Weiss C, Wehling M. Consensus validation of the FORTA (Fit fOR The Aged) list: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly. Drugs Aging. 2014;31(2):131–40.  https://doi.org/10.1007/s40266-013-0146-0.PubMedCrossRefGoogle Scholar
  56. 56.
    Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Deutsches Ärzteblatt Int. 2010;107(31–32):543–51.  https://doi.org/10.3238/arztebl.2010.0543.Google Scholar
  57. 57.
    Chang CB, Yang SY, Lai HY, et al. Using published criteria to develop a list of potentially inappropriate medications for elderly patients in Taiwan. Pharmacoepidemiol Drug Saf. 2012;21(12):1269–79.  https://doi.org/10.1002/pds.3274.PubMedCrossRefGoogle Scholar
  58. 58.
    Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–51.PubMedCrossRefGoogle Scholar
  59. 59.
    George J, Phun YT, Bailey MJ, et al. Development and validation of the Medication Regimen Complexity Index. Ann Pharmacother. 2004;38(9):1369–76.  https://doi.org/10.1345/aph.1D479.PubMedCrossRefGoogle Scholar
  60. 60.
    Linjakumpu T, Hartikainen S, Klaukka T, et al. A model to classify the sedative load of drugs. Int J Geriatr Psychiatry. 2003;18(6):542–4.  https://doi.org/10.1002/gps.846.PubMedCrossRefGoogle Scholar
  61. 61.
    Boustani M, Campbell N, Munger S, et al. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4(3):311–20.  https://doi.org/10.2217/1745509X.4.3.311.CrossRefGoogle Scholar
  62. 62.
    Evans DC, Gerlach AT, Christy JM, et al. Pre-injury polypharmacy as a predictor of outcomes in trauma patients. Int J Crit Illn Inj Sci. 2011;1(2):104–9.  https://doi.org/10.4103/2229-5151.84793.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Gnjidic D, Le Couteur DG, Abernethy DR, et al. Drug burden index and Beers criteria: impact on functional outcomes in older people living in self-care retirement villages. J Clin Pharmacol. 2012;52(2):258–65.  https://doi.org/10.1177/0091270010395591.PubMedCrossRefGoogle Scholar
  64. 64.
    Wehling M, Burkhardt H, Kuhn-Thiel A, et al. VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification. Age Ageing. 2016;45(2):262–7.  https://doi.org/10.1093/ageing/afv200.PubMedCrossRefGoogle Scholar
  65. 65.
    Pugh MJ, Marcum ZA, Copeland LA, et al. The quality of quality measures: HEDIS® quality measures for medication management in the elderly and outcomes associated with new exposure. Drugs Aging. 2013;30(8):645–54.  https://doi.org/10.1007/s40266-013-0086-8.PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Henschel F, Redaelli M, Siegel M, et al. Correlation of incident potentially inappropriate medication prescriptions and hospitalization: an analysis based on the PRISCUS list. Drugs Real World Outcomes. 2015;2(3):249–59.  https://doi.org/10.1007/s40801-015-0035-4.PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Frankenthal D, Lerman Y, Kalendaryev E, et al. Intervention with the screening tool of older persons potentially inappropriate Prescriptions/Screening Tool to Alert doctors to Right Treatment criteria in elderly residents of a chronic geriatric facility: a randomized clinical trial. J Am Geriatr Soc. 2014;62(9):1658–65.  https://doi.org/10.1111/jgs.12993.PubMedCrossRefGoogle Scholar
  68. 68.
    Moriarty F, Bennett K, Cahir C, et al. Potentially inappropriate prescribing according to STOPP and START and adverse outcomes in community-dwelling older people: a prospective cohort study. Br J Clin Pharmacol. 2016;82(3):849–57.  https://doi.org/10.1111/bcp.12995.PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Gosch M, Wortz M, Nicholas JA, et al. Inappropriate prescribing as a predictor for long-term mortality after hip fracture. Gerontology. 2014;60(2):114–22.  https://doi.org/10.1159/000355327.PubMedCrossRefGoogle Scholar
  70. 70.
    Tosato M, Landi F, Martone AM, et al. Potentially inappropriate drug use among hospitalised older adults: results from the CRIME study. Age Ageing. 2014;43(6):767–73.  https://doi.org/10.1093/ageing/afu029.PubMedCrossRefGoogle Scholar
  71. 71.
    Cahir C, Bennett K, Teljeur C, et al. Potentially inappropriate prescribing and adverse health outcomes in community dwelling older patients. Br J Clin Pharmacol. 2013;77(1):201–10.  https://doi.org/10.1111/bcp.12161.PubMedCentralCrossRefGoogle Scholar
  72. 72.
    Maggiore RJ, Dale W, Gross CP, et al. Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatment. J Am Geriatr Soc. 2014;62(8):1505–12.  https://doi.org/10.1111/jgs.12942.PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Price SD, Holman CD, Sanfilippo FM, et al. Impact of specific Beers criteria medications on associations between drug exposure and unplanned hospitalisation in elderly patients taking high-risk drugs: a case-time-control study in Western Australia. Drugs Aging. 2014;31(4):311–25.  https://doi.org/10.1007/s40266-014-0164-6.PubMedCrossRefGoogle Scholar
  74. 74.
    Onder G, Landi F, Liperoti R, et al. Impact of inappropriate drug use among hospitalized older adults. Eur J Clin Pharmacol. 2005;61(5–6):453–9.  https://doi.org/10.1007/s00228-005-0928-3.PubMedCrossRefGoogle Scholar
  75. 75.
    Fick DM, Mion LC, Beers MH, et al. Health outcomes associated with potentially inappropriate medication use in older adults. Res Nurs Health. 2008;31(1):42–51.  https://doi.org/10.1002/nur.20232.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Stockl KM, Le L, Zhang S, et al. Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly. Am J Manag Care. 2010;16(1):e1–10.PubMedGoogle Scholar
  77. 77.
    Dedhiya SD, Hancock E, Craig BA, et al. Incident use and outcomes associated with potentially inappropriate medication use in older adults. Am J Geriatr Pharmacother. 2010;8(6):562–70.  https://doi.org/10.1016/s1543-5946(10)80005-4.PubMedCrossRefGoogle Scholar
  78. 78.
    Pasina L, Djade CD, Tettamanti M, et al. Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients: results from the REPOSI study. J Clin Pharm Ther. 2014;39(5):511–5.  https://doi.org/10.1111/jcpt.12178.PubMedCrossRefGoogle Scholar
  79. 79.
    Somers A, Mallet L, van der Cammen T, et al. Applicability of an adapted medication appropriateness index for detection of drug-related problems in geriatric inpatients. Am J Geriatr Pharmacother. 2012;10(2):101–9.  https://doi.org/10.1016/j.amjopharm.2012.01.003.PubMedCrossRefGoogle Scholar
  80. 80.
    Olsson IN, Runnamo R, Engfeldt P. Medication quality and quality of life in the elderly, a cohort study. Health Qual Life Outcomes. 2011;9:95.  https://doi.org/10.1186/1477-7525-9-95.PubMedCrossRefGoogle Scholar
  81. 81.
    Hanlon JT, Sloane RJ, Pieper CF, et al. Association of adverse drug reactions with drug-drug and drug-disease interactions in frail older outpatients. Age Ageing. 2011;40(2):274–7.  https://doi.org/10.1093/ageing/afq158.PubMedCrossRefGoogle Scholar
  82. 82.
    Lund BC, Carnahan RM, Egge JA, et al. Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother. 2010;44(6):957–63.  https://doi.org/10.1345/aph.1M65710.1345/aph.1M657A.PubMedCrossRefGoogle Scholar
  83. 83.
    Wimmer BC, Dent E, Visvanathan R, et al. Polypharmacy and medication regimen complexity as factors associated with hospital discharge destination among older people: a prospective cohort study. Drugs Aging. 2014;31(8):623–30.  https://doi.org/10.1007/s40266-014-0185-1.PubMedCrossRefGoogle Scholar
  84. 84.
    Wimmer BC, Dent E, Bell JS, et al. Medication regimen complexity and unplanned hospital readmissions in older people. Ann Pharmacother. 2014;48(9):1120–8.  https://doi.org/10.1177/1060028014537469.PubMedCrossRefGoogle Scholar
  85. 85.
    Peklar J, O’Halloran AM, Maidment ID, et al. Sedative load and frailty among community-dwelling population aged ≥ 65 years. J Am Med Dir Assoc. 2015;16(4):282–9.  https://doi.org/10.1016/j.jamda.2014.10.010.PubMedCrossRefGoogle Scholar
  86. 86.
    Gnjidic D, Le Couteur DG, Hilmer SN, et al. Sedative load and functional outcomes in community-dwelling older Australian men: the CHAMP study. Fundam Clin Pharmacol. 2014;28(1):10–9.  https://doi.org/10.1111/j.1472-8206.2012.01063.x.PubMedCrossRefGoogle Scholar
  87. 87.
    Taipale HT, Bell JS, Soini H, et al. Sedative load and mortality among residents of long-term care facilities: a prospective cohort study. Drugs Aging. 2009;26(10):871–81.  https://doi.org/10.2165/11317080-000000000-00000.PubMedCrossRefGoogle Scholar
  88. 88.
    Fox C, Richardson K, Maidment ID, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc. 2011;59(8):1477–83.  https://doi.org/10.1111/j.1532-5415.2011.03491.x.PubMedCrossRefGoogle Scholar
  89. 89.
    Pasina L, Djade CD, Lucca U, et al. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs Aging. 2013;30(2):103–12.  https://doi.org/10.1007/s40266-012-0044-x.PubMedCrossRefGoogle Scholar
  90. 90.
    Lampela P, Lavikainen P, Garcia-Horsman JA, et al. Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study. Drugs Aging. 2013;30(5):321–30.  https://doi.org/10.1007/s40266-013-0063-2.PubMedCrossRefGoogle Scholar
  91. 91.
    Zimmerman KM, Salow M, Skarf LM, et al. Increasing anticholinergic burden and delirium in palliative care inpatients. Palliat Med. 2014;28(4):335–41.  https://doi.org/10.1177/0269216314522105.PubMedCrossRefGoogle Scholar
  92. 92.
    Kersten H, Molden E, Tolo IK, et al. Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2013;68(3):271–8.  https://doi.org/10.1093/gerona/gls176.PubMedCrossRefGoogle Scholar
  93. 93.
    Lowry E, Woodman RJ, Soiza RL, et al. Associations between the anticholinergic risk scale score and physical function: potential implications for adverse outcomes in older hospitalized patients. J Am Med Dir Assoc. 2011;12(8):565–72.  https://doi.org/10.1016/j.jamda.2011.03.006.PubMedCrossRefGoogle Scholar
  94. 94.
    Koshoedo S, Soiza RL, Purkayastha R, et al. Anticholinergic drugs and functional outcomes in older patients undergoing orthopaedic rehabilitation. Am J Geriatr Pharmacother. 2012;10(4):251–7.  https://doi.org/10.1016/j.amjopharm.2012.06.003.PubMedCrossRefGoogle Scholar
  95. 95.
    Kersten H, Molden E, Willumsen T, et al. Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from Norwegian nursing homes. Br J Clin Pharmacol. 2013;75(3):842–9.  https://doi.org/10.1111/j.1365-2125.2012.04411.x.PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Marcum ZA, Wirtz HS, Pettinger M, et al. Anticholinergic medication use and falls in postmenopausal women: Findings from the Women’s Health Initiative cohort study. BMC Geriatr. 2016;16:76.  https://doi.org/10.1186/s12877-016-0251-0.PubMedPubMedCentralCrossRefGoogle Scholar
  97. 97.
    Kumpula EK, Bell JS, Soini H, et al. Anticholinergic drug use and mortality among residents of long-term care facilities: a prospective cohort study. J Clin Pharmacol. 2011;51(2):256–63.  https://doi.org/10.1177/0091270010368410.PubMedCrossRefGoogle Scholar
  98. 98.
    Mubang RN, Stoltzfus JC, Cohen MS, et al. Comorbidity-polypharmacy score as predictor of outcomes in older trauma patients: a retrospective validation study. World J Surg. 2015;39(8):2068–75.  https://doi.org/10.1007/s00268-015-3041-5.PubMedCrossRefGoogle Scholar
  99. 99.
    Evans DC, Cook CH, Christy JM, et al. Comorbidity-polypharmacy scoring facilitates outcome prediction in older trauma patients. J Am Geriatr Soc. 2012;60(8):1465–70.  https://doi.org/10.1111/j.1532-5415.2012.04075.x.PubMedCrossRefGoogle Scholar
  100. 100.
    Justiniano CF, Coffey RA, Evans DC, et al. Comorbidity-polypharmacy score predicts in-hospital complications and the need for discharge to extended care facility in older burn patients. J Surg Res. 2014;36(1):193–6.  https://doi.org/10.1097/bcr.0000000000000094.Google Scholar
  101. 101.
    Mangoni AA, van Munster BC, Woodman RJ, et al. Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures. Am J Geriatr Psychiatry. 2013;21(8):785–93.  https://doi.org/10.1016/j.jagp.2013.01.012.PubMedCrossRefGoogle Scholar
  102. 102.
    Bostock CV, Soiza RL, Mangoni AA. Associations between different measures of anticholinergic drug exposure and Barthel Index in older hospitalized patients. Ther Adv Drug Saf. 2013;4(6):235–45.  https://doi.org/10.1177/2042098613500689.PubMedPubMedCentralCrossRefGoogle Scholar
  103. 103.
    Dispennette R, Elliott D, Nguyen L, et al. Drug burden index score and anticholinergic risk scale as predictors of readmission to the hospital. Consul Pharm. 2014;29(3):158–68.  https://doi.org/10.4140/TCP.n.2014.158.CrossRefGoogle Scholar
  104. 104.
    Hilmer SN, Mager DE, Simonsick EM, et al. Drug burden index score and functional decline in older people. Am J Med. 2009;122(12):1142–9.  https://doi.org/10.1016/j.amjmed.2009.02.021.PubMedPubMedCentralCrossRefGoogle Scholar
  105. 105.
    Gnjidic D, Cumming RG, Le Couteur DG, et al. Drug burden index and physical function in older Australian men. Br J Clin Pharmacol. 2009;68(1):97–105.  https://doi.org/10.1111/j.1365-2125.2009.03411.x.PubMedPubMedCentralCrossRefGoogle Scholar
  106. 106.
    Gnjidic D, Bell JS, Hilmer SN, et al. Drug burden index associated with function in community-dwelling older people in Finland: a cross-sectional study. Ann Med. 2012;44(5):458–67.  https://doi.org/10.3109/07853890.2011.573499.PubMedCrossRefGoogle Scholar
  107. 107.
    Wilson NM, Hilmer SN, March LM, et al. Associations between drug burden index and mortality in older people in residential aged care facilities. Drugs Aging. 2012;29(2):157–65.  https://doi.org/10.2165/11598570-000000000-00000.PubMedCrossRefGoogle Scholar
  108. 108.
    Wilson NM, Hilmer SN, March LM, et al. Associations between drug burden index and physical function in older people in residential aged care facilities. Age Ageing. 2010;39(4):503–7.  https://doi.org/10.1093/ageing/afq053.PubMedCrossRefGoogle Scholar
  109. 109.
    Wilson NM, Hilmer SN, March LM, et al. Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc. 2011;59(5):875–80.  https://doi.org/10.1111/j.1532-5415.2011.03386.x.PubMedCrossRefGoogle Scholar
  110. 110.
    Best O, Gnjidic D, Hilmer SN, et al. Investigating polypharmacy and drug burden index in hospitalised older people. Intern Med J. 2013;43(8):912–8.  https://doi.org/10.1111/imj.12203.PubMedCrossRefGoogle Scholar
  111. 111.
    Dauphinot V, Faure R, Omrani S, et al. Exposure to anticholinergic and sedative drugs, risk of falls, and mortality: an elderly inpatient, multicenter cohort. J Clin Psychopharmacol. 2014;34(5):565–70.  https://doi.org/10.1097/jcp.0000000000000195.PubMedCrossRefGoogle Scholar
  112. 112.
    Lonnroos E, Gnjidic D, Hilmer SN, et al. Drug burden index and hospitalization among community-dwelling older people. Drugs Aging. 2012;29(5):395–404.  https://doi.org/10.2165/11631420-000000000-00000.PubMedCrossRefGoogle Scholar
  113. 113.
    Lowry E, Woodman RJ, Soiza RL, et al. Drug burden index, physical function, and adverse outcomes in older hospitalized patients. J Clin Pharmacol. 2012;52(10):1584–91.  https://doi.org/10.1177/0091270011421489.PubMedCrossRefGoogle Scholar
  114. 114.
    Gnjidic D, Hilmer SN, Blyth FM, et al. High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther. 2012;91(3):521–8.  https://doi.org/10.1038/clpt.2011.258.PubMedCrossRefGoogle Scholar
  115. 115.
    Kaufmann CP, Tremp R, Hersberger KE, et al. Inappropriate prescribing: a systematic overview of published assessment tools. Eur J Clin Pharmacol. 2014;70(1):1–11.  https://doi.org/10.1007/s00228-013-1575-8.PubMedCrossRefGoogle Scholar
  116. 116.
    Villalba-Moreno AM, Alfaro-Lara ER, Perez-Guerrero MC, et al. Systematic review on the use of anticholinergic scales in poly pathological patients. Arch Gerontol Geriatr. 2016;62:1–8.  https://doi.org/10.1016/j.archger.2015.10.002.PubMedCrossRefGoogle Scholar
  117. 117.
    Wang KCM, Veluswamy R. Evidence-based strategies to reduce polypharmacy: a review. OA Elderly Med. 2013;1:6.Google Scholar
  118. 118.
    Levy HB, Marcus EL, Christen C. Beyond the Beers criteria: a comparative overview of explicit criteria. Ann Pharmacother. 2010;44(12):1968–75.  https://doi.org/10.1345/aph.1P426.PubMedCrossRefGoogle Scholar
  119. 119.
    O’Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing. 2008;37(2):138–41.  https://doi.org/10.1093/ageing/afm189.PubMedCrossRefGoogle Scholar
  120. 120.
    Taipale HT, Hartikainen S, Bell JS. A comparison of four methods to quantify the cumulative effect of taking multiple drugs with sedative properties. Am J Geriatr Pharmacother. 2010;8(5):460–71.  https://doi.org/10.1016/j.amjopharm.2010.10.004.PubMedCrossRefGoogle Scholar
  121. 121.
    Cadogan CA, Ryan C, Hughes CM. Appropriate polypharmacy and medicine safety: when many is not too many. Drug Saf. 2016;39(2):109–16.  https://doi.org/10.1007/s40264-015-0378-5.PubMedCrossRefGoogle Scholar
  122. 122.
    Hill-Taylor B, Walsh KA, Stewart S, et al. Effectiveness of the STOPP/START (Screening Tool of Older persons’ Potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther. 2016;41(2):158–69.  https://doi.org/10.1111/jcpt.12372.PubMedCrossRefGoogle Scholar
  123. 123.
    Lund BC, Steinman MA, Chrischilles EA, et al. Beers criteria as a proxy for inappropriate prescribing of other medications among older adults. Ann Pharmacother. 2011;45(11):1363–70.  https://doi.org/10.1345/aph.1Q361.PubMedPubMedCentralCrossRefGoogle Scholar
  124. 124.
    Australian Medicines Handbook Pty Ltd. Prescribing for the elderly. In: The Australian Medicines Handbook. Australian Medicines Handbook Pty Ltd. 2017. https://amhonline-amh-net-au.access.library.unisa.edu.au/guides/guide-elderly. Accessed 10 May 2017.
  125. 125.
    Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–34.  https://doi.org/10.1001/jamainternmed.2015.0324.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical SciencesUniversity of South AustraliaAdelaideAustralia
  2. 2.Department of PharmacyRoyal Adelaide HospitalAdelaideAustralia
  3. 3.Department of Clinical PharmacologyRoyal Adelaide HospitalAdelaideAustralia
  4. 4.Discipline of Pharmacology, School of MedicineUniversity of AdelaideAdelaideAustralia

Personalised recommendations